Diagnosoft, Inc. has received FDA approval for its HARP software that assists physicians in the analysis of magnetic resonance (MR) images by providing quantitative measurements and visualization of regional heart function.

Developed at and licensed from Johns Hopkins University, the technology is the first FDA approved software designed for the analysis of tagged MR images.

The Mobile Acuity LT Central Monitoring Station is designed to allow emergency caregivers to establish an Emergency Medical Delivery Area when and where it's needed. Central station monitoring is made to be deployed immediately on site in response to emergency situations to increase the level and timeliness of care for victims involved.

The FDA gave Humanitarian Device Exemption (HDE) approval for the AbioCor Implantable Replacement Heart (AbioCor). The approval will provide patients suffering from heart failure on both sides of their heart (bi-ventricular) and who have no other alternative a viable option for extending the quality of their life.
The AbioCor is the first completely self-contained artificial heart that may allow patients more time at home, without wires or tubes piercing through their skin. This technology provides patients with complete mobility and remote diagnostics.

In the CCU, ED or anywhere ECG records are needed, the Pyramis ECG Management System reportedly provides instant access to information, automating the process of managing information and eliminating time spent locating and retrieving records.

The company said the system integrates disparate patient data from legacy systems into a single, patient-centric, cardiology record with fast, accurate, reliable ECG processing, retrieval and distribution.

The Medtronic CareLink Network is the Internet-based remote monitoring service for patients with Medtronic implanted cardiac devices and their clinics.
Using a standard phone line, patients can send their device information to their clinics from the comfort of their home or while traveling.
The monitor plugs into a standard phone line, gathers the information and sends it to a secure storage site. The Internet is not needed to transmit.

The LATITUDE Patient Management System by Boston Scientific has FDA approval to be used in virtually all of the company's implantable defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds). This approval increases the number of patients eligible to receive the benefits of home monitoring by more than 150,000 in the U.S.

The AfibAlert Atrial Fibrillation Monitor is a healthcare provider-prescribed ambulatory cardiac monitor for improved atrial fibrillation management. The pocket-sized monitor is a tool for the more than two million Americans who suffer from atrial fibrillation.

The NaviStar ThermoCool Catheter is available for the treatment of adults with specific rapid heartbeats who have already experienced failure with other treatments, such as device or other antiarrhythmic drug therapy. These specific rapid heartbeats are scientifically known as ventricular tachycardia (VT) that arise following a heart attack. The catheter is the first FDA-approved catheter to treat both mappable and unmappable VTs. The expanded indication provides cardiac electrophysiologists with a new treatment option for the estimated three million people in the U.S.

Developed to help hospitals seamlessly bring their entire portfolio of wireless services and applications together on a single infrastructure, Enterprise Access with Wireless Medical Telemetry Service (WMTS) enables healthcare organizations to harness the power of next-generation wireless computing throughout their facilities.

HeartCentrix is a software solution that enables Burdick and Quinton stress, Holter and ECG devices to communicate seamlessly with physician office-based electronic medical record (EMR) systems. Cardiac Science owns the Burdick and Quinton brands.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now